Search

everythinglearnresearchcommunity

for

Search:↓

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Hair loss is common in IBD patients, and some medications may lower the risk.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Transplant patients often get skin problems, with treatments varying by condition.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

The document gives treatment advice for various skin conditions, like using metronidazole for perioral dermatitis and minoxidil for hair loss.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Effective symptom management in IBD improves quality of life and prevents complications.

Chemotherapy in children often causes hair loss, nausea, vomiting, and mood swings.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.